Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K5EI
|
||||
| Former ID |
DNC009010
|
||||
| Drug Name |
Naphthalen-2-yl cyclohexylcarbamate
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529791] | ||
| Formula |
C17H19NO2
|
||||
| Canonical SMILES |
C1CCC(CC1)NC(=O)OC2=CC3=CC=CC=C3C=C2
|
||||
| InChI |
1S/C17H19NO2/c19-17(18-15-8-2-1-3-9-15)20-16-11-10-13-6-4-5-7-14(13)12-16/h4-7,10-12,15H,1-3,8-9H2,(H,18,19)
|
||||
| InChIKey |
ZYHUWMGJJOBBCF-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529791] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||